aluminum sulfate has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubey, S; Garg, H; Gupta, JC; Talwar, GP | 1 |
| Bhattachary-Chatterjee, M; Chakraborty, M; Chatterjee, SK; Das, R; Foon, KA; Nath Baral, R; Zeytin, H | 1 |
1 review(s) available for aluminum sulfate and Breast Neoplasms
| Article | Year |
|---|---|
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
1 trial(s) available for aluminum sulfate and Breast Neoplasms
| Article | Year |
|---|---|
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
1 other study(ies) available for aluminum sulfate and Breast Neoplasms
| Article | Year |
|---|---|
Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Breast Neoplasms; Cancer Vaccines; Disease Models, Animal; Female; Immunization; Immunotherapy; Inhibitor of Apoptosis Proteins; Mice, Inbred BALB C; Recombinant Proteins; Repressor Proteins; Survivin | 2018 |